May we use Google Analytics cookies to measure visits to our public pages? You can decline and continue using the site, or change your choice at any time.
What we measure
After you allow analytics, Google receives public page paths, language and browser/device information to help us understand readership. We omit search text, URL parameters, account pages, community pages, watchlists, portfolio records and form entries. Advertising personalization is disabled. Your choice is saved in this browser for 180 days. This choice controls FinanceVelix analytics, not the separate market widgets you open. We also count calculator completions, coin page views, sharing actions, image downloads and affiliate link clicks. Calculation inputs and results are not sent. Optional diagnostics also measure page and chart loading times, interaction responsiveness and layout shifts, compared by country and device in Google Analytics. Google Analytics infers the country; this site does not collect precise location. After consent, we also count moves between articles, assets and tools. Symbols entered in forms and calculation values are not sent.
Bristol Myers stock was quoted at $61.61 on October 27, 2026, after rising 46.8% over the preceding year. Shares of Bristol-Myers Squibb were also up 19.3% since the start of 2026.
Bristol Myers stock performance
The one-year and year-to-date gains cover different periods. Neither figure describes the stock’s movement on October 27 alone, and the $61.61 quotation was not identified as a closing price.
The available information does not establish what drove the share-price gains.
Trailing earnings per share
Bristol-Myers Squibb had earnings per share of $6.14 for the trailing 12 months, excluding non-recurring items. That figure measures historical earnings rather than a forecast.
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
Comments
Be respectful. No spam, impersonation or private credentials. Ordinary posts and comments appear immediately; suspicious links are held for review.
Please wait…